Invention Grant
- Patent Title: Use of myeloid cell biomarkers for the diagnosis of cancer
-
Application No.: US13239011Application Date: 2011-09-21
-
Publication No.: US09671404B2Publication Date: 2017-06-06
- Inventor: Harpreet Singh , Regina Mendrzyk , Steffan Walter , Vincezq Bronte , Susanna Mandruzzato
- Applicant: Harpreet Singh , Regina Mendrzyk , Steffan Walter , Vincezq Bronte , Susanna Mandruzzato
- Applicant Address: DE Munich
- Assignee: IMMATICS BIOTECHNOLOGIES GMBH
- Current Assignee: IMMATICS BIOTECHNOLOGIES GMBH
- Current Assignee Address: DE Munich
- Agency: McBee Moore Woodward & Vanik IP, LLC.
- Priority: GB1015765.9 20100921
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/50
Abstract:
The present invention relates to the use of myeloid cell biomarkers for the differential diagnosis, prognosis, and monitoring of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to monitoring the effect of a treatment against renal cell carcinoma (RCC) or colorectal cancer (CRC), and establishing a prognosis of the outcome of the treatment of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to panels of cellular biomarkers for use in the above methods, in particular multicolor panels for measuring said biomarkers.
Public/Granted literature
- US20120070461A1 USE OF MYELOID CELL BIOMARKERS FOR THE DIAGNOSIS OF CANCER Public/Granted day:2012-03-22
Information query
IPC分类:
